Why the study?
Does the NOS pathway compensate for dysfunctional Ca(2+)-activated K(+) channel-mediated relaxation in small mesenteric arteries from hypertensive rats?
Population
Third-order mesenteric arteries from normotensive, angiotensin II-infused, high-salt, ANG high-salt…
Comparison
Acetylcholine-induced vasorelaxation with and… vs Normotensive, high-salt, and placebo rats
Design
Preclinical
Authors
Loading...
Preclinical NOS compensation in hypertensive rats should not guide therapy; leaves open human mechanistic validation.
Does the NOS pathway compensate for dysfunctional Ca(2+)-activated K(+) channel-mediated relaxation in small mesenteric arteries from hypertensive rats?
In hypertensive rats, Ca(2+)-activated K(+) channel-mediated relaxation is dysfunctional, and the NOS pathway compensates to maintain vasorelaxation via cGMP and H2O2 production.
Kang et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: